Mural Oncology plc
Biotechnology
Healthcare
MURA
17.27 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.07
52 week high
4.43
high
2.10
52 week low
0.00
low
2.07
growth
-38.17 %
previous Close
2.07
P/E ratio
-1
market cap
31.18 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-47.98 M
-44.80 %
eps
-2.78 %
-44.04 %
eps surprise
-152.73 %
net profit margin
-4798200000.00 %
0.00 %
operating incoming
-31.36 M
8.81 %
net change in cash
-29.59 M
-236.99 %
cash on hand
77.09 M
-27.73 %
cost of revenue
0.00 %
top top